Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/15/15  and contains information from public web pages and contributions from the ZoomInfo community.

Professor of Cell Biology

NYU School of Medicine
Phone: (212) ***-****  
Email: m***@***.edu
NYU
530 First Avenue
New York , New York 10016
United States

Company Description: One of the world's premier academic medical institutions for more than 167 years, NYU Langone Medical Center continues to be a leader in patient care, physician...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • Ph.D.
  • Ph.D.
    Carnegie Mellon University
  • M.S. , Computer Science
    Carnegie Mellon University
115 Total References
Web References
Dr. Bud ...
www.globalminded.org, 15 Dec 2015 [cached]
Dr. Bud Mishra
Professor at NYU's Courant Institute of Mathematical Sciences/Mt. Sinai School of Medicine/NYU School of Medicine
Bud Mishra is a professor of computer science and mathematics at NYU's Courant Institute of Mathematical Sciences, professor of human genetics at Mt Sinai School of Medicine, and a professor of cell biology at NYU School of Medicine. Bud has a degree in Sciences from Utkal University, in Electronics and Communication Engineering from Indian Institute of Technology (IIT), Kharagpur, and MS and PhD degrees in Computer Science from Carnegie-Mellon University. Bud is also a visiting scholar at CSHL's Center for Quantitative Biology. From 2001-04, he was a professor at the Watson School of Biological Sciences, Cold Spring Harbor Lab (CSHL) and from 2003-2006, a Visiting Professor at Tata Institute of Fundamental Research (TIFR).
Bud is an IIT, Kharagpur Distinguished Alumnus, NYSTAR Distinguished Professor, AAAS Fellow (engineering: robotics, hardware verification and computational biology), IEEE fellow (robotics and automation) and a fellow of the ACM (computational biology and symbolic computation).
Join Acclaimed NYU Professor & Data ...
www.genesismedia.com, 16 July 2014 [cached]
Join Acclaimed NYU Professor & Data Scientist Bud Mishra and Genesis Media on July 29th
NEW YORK - July 16, 2014 - Genesis Media, a video advertising technology platform, today announced the next event in its Publisher Summit series titled, "The DNA of Data Science. The two-hour event will be held at NYU's famed Courant Institute on July 29th.in New York City. Genesis Media's Publisher Summit series brings together advertising, marketing, and publishing experts for dynamic conversations around data science.
Genesis Media Co-founder and Chief Product Officer Josh Feuer will join Bud Mishra, professor of computer science, mathematics and cell biology at NYU's Courant Institute to discuss the importance of data science and its overall impact on the future of digital advertising.
...
Bud Mishra, Ph.D.; Professor of Computer Science, Mathematics and Cell Biology; NYU's
...
"For this event, our team is thrilled to join Genesis' Data Science Advisor Bud Mishra, whose multidisciplinary methodologies are directly applicable to adtech innovation."
...
Genesis Media Announces Partnership with Acclaimed NYU Professor and Data Scientist Bud Mishra
Professor Bud Mishra, PhD, ...
www.prweb.com, 28 May 2014 [cached]
Professor Bud Mishra, PhD, joins the Science Advisory Board of Deep Knowledge Ventures' portfolio company, InSilico Medicine Inc.
...
Prof. Bud Mishra is one of those rare scientists, who excelled in the many fields including physics, engineering, computer science, robotics, finance, genomics, epigenetics, genetics and disease modeling.
Baltimore, Maryland (PRWEB) May 28, 2014
Today Insilico Medicine, Inc., a Deep Knowledge Ventures' portfolio company based in Baltimore, that is using advances in genomics to discover new therapies to target aging and age-related diseases, announced that leading computer scientist Professor Bud Mishra has joined its Science Advisory Board. A recent investment, Insilico Medicine, Inc. holds an exclusive license to drug discoveries made using another DVK portfolio company, Pathway Pharmaceuticals,' OncoFINDER tool, which predicts drug efficacy through a proprietary gene expression analysis algorithm. The addition of leading computer scientist Prof. Mishra's expertise to that of S.A.B. Chairman Dr Charles Cantor, former Director of the Human Genome Project, places InSilico Medicine in the vanguard of bioinformatics and commercial life extension initiatives.
...
With a group like this, I hope to engage in a collective 'head-banging' against the amazingly challenging biomedical problems we face, using some of the most advanced science and technologies in development," said Professor Bud Mishra.
Prof. Mishra's research career over the last thirty-four years has consistently focused upon information-technology-based approaches to real-life problems of enormous societal impact: namely, cyber security solutions, cancer characterization through genomic data analysis, fast and cheap technology for DNA sequencing with applications to genetics, computational systems biology tools with applications to drug discovery, robot hand design with industrial applications, hierarchical hardware model checking and symbolic computation with applications to robot kinematics. More importantly, many of these research programs have also been instrumental in creation of new fields (often outside traditional computer science), where computing now occupies a central position.
As an example, around 1983, Mishra and Clarke proposed an innovative approach to computer hardware verification via model checking and applied it to a well-known asynchronous FIFO queue element circuit, designed by Caltech's Chuck Seitz, to discover that this circuit had a serious race condition.
...
In the mean time, Prof. Mishra has continued to develop these ideas and apply them to robotics, control theory and more recently to systems biology through algorithmic algebraic model checking. Around 1997, Prof. Mishra began to collaborate with biologists and chemists to develop the first single molecule genomic technology to map and sequence genomes rapidly, inexpensively and with small amount materials. The success of this technology depended on Mishra's innovations in probabilistic analysis, Bayesian statistics and efficient algorithmic techniques. The technology is being commercialized by various biotech companies; it promises to have an enormous impact on our understanding of infectious, genetic and genomic diseases like cancer and neuro-degeneration. Mishra has also recently advanced this technology to improve its resolution using AFM-based nano-technology. As in hardware verification in the past, this new field of single-molecule genomics has now begun to attract a thriving multi-disciplinary community.
He has industrial experience in Computer Science (Tartan Laboratories, and ATTAP), Finance (Instadat ,Tudor Investment and PRF, LLC), Robotics and Biotechnology (MRTechnology, OpGen, and Bioarrays). He has been editor of Molecular Cancer Therapeutics, AMRX (Applied Mathematics Research Exchange), Transactions on Systems Biology, and Nanotechnology: Science and Applications, and author of a textbook on algorithmic algebra and more than two hundred archived publications. He also holds adjunct professorship at Tata Institute of Fundamental Research in Mumbai, India. From 2001-04, he was a professor at the Watson School of Biological Sciences, Cold Spring Harbor Lab. He is a co-inventor of Optical Mapping, Array Mapping, and Copy-Number Variation Mapping in biotechnologies. His other technological inventions extend to model checkers for circuit verification, robot grasping and fixturing algorithms, reactive robotics, real-time schedulers, and nanotechnology for DNA profiling.
"Prof. Bud Mishra is one of those rare scientists, who excelled in the many fields including physics, engineering, computer science, robotics, finance, genomics, epigenetics, genetics and disease modeling. In the course of his career, Dr. Mishra has been mentored by many scientific and engineering luminaries and has trained two generations of computer science visionaries now leading various cutting edge research at DEShaw, Blackstone, Google, and many other leading companies. We are fascinated by Dr. Mishra's work in cancer genetics and application of mathematical modeling to the many processes related to human aging," said Alex Zhavoronkov, PhD, CEO of InSilico Medicine, Inc.
...
In particular I have long hoped for an opportunity to do something direct with Bud Mishra and now that he has also joined the SAB of Insilico Medicine we have a forum to promote brain storming and interactions," said Dr. Charles Cantor, a Professor at Boston University, the former director of the Human Genome Project with the Department of Energy and the Chair of the Science Advisory Board of InSilico Medicine, Inc.
Genesis Media Announces ...
www.genesismedia.com, 29 July 2014 [cached]
Genesis Media Announces Partnership with Acclaimed NYU Professor and Data Scientist Bud Mishra GenesisMedia > Genesis Media Announces Partnership with Acclaimed NYU Professor and Data Scientist Bud Mishra GenesisMedia - The Attention Platform
...
Genesis Media Announces Partnership with Acclaimed NYU Professor and Data Scientist Bud Mishra
Partnership Unveiled at Genesis Media's "The DNA of Data Science" Event at the Courant Institute of Mathematical Science
NEW YORK - July 29, 2014 - Genesis Media, a video advertising technology platform, today announced its partnership with Bud Mishra, Ph.D., professor of computer science, mathematics and cell biology at New York University's Courant Institute and School of Medicine. As a result, Dr. Mishra will work closely with Genesis Media to help the company define and execute its strategy, while leveraging the power of data science to continue to strengthen its highly differentiated, proprietary technology platform.
"We're excited to continue this next chapter of ad tech innovation alongside Bud," said Josh Feuer, Genesis Media co-founder and chief product officer.
...
Deep data insights are an integral driver for the Genesis Media platform, and the foremost focus of Dr. Mishra's research. The partnership will dissect the central role of data science in the evolution and future of digital advertising, and compare its impact to other sectors heavily reliant on data science, including finance, health and business.
"We're at an exciting time in technology innovation where connectivity is quantifiable. We can use data science to gain insights into forms of human behavior, which is incredibly valuable to advertisers and publishers, medicine, social research, finance and much more," said Dr. Mishra.
Today Insilico Medicine, Inc., ...
www.deepknowledgeventures.com, 28 Aug 2014 [cached]
Today Insilico Medicine, Inc., a Deep Knowledge Ventures' portfolio company based in Baltimore, that is using advances in genomics to discover new therapies to target aging and age-related diseases, announced that leading computer scientist Professor Bud Mishra has joined its Science Advisory Board.
Other People with the name "Mishra":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304